Navigation Links
FASEB Welcomes New President, William T. Talman, M.D.
Date:7/1/2010

BETHESDA, Md., July 1 /PRNewswire-USNewswire/ -- William T. Talman, M.D., assumed office as the 95th President of the Federation of American Societies for Experimental Biology (FASEB) on July 1, 2010. Talman is a Professor of Neurology and Neuroscience at the University of Iowa and is a practicing physician at the University Hospital and at the Iowa City Veterans Affairs (VA) hospital where he is the Chief of the Neurology Service. He will serve for one year as the leader of FASEB, a coalition of 23 member societies comprising more than 100,000 scientists and engineers.

"The opportunities for continued progress have never been greater, but those opportunities depend on adequate resources," Talman stated. "In 2009, supplemental appropriations from the American Recovery and Reinvestment Act (ARRA) restored purchasing power at the National Institutes of Health (NIH) and provided a timely investment in biomedical research across the nation. However, if we return to pre-ARRA funding levels in fiscal year 2011, we will have to curtail many promising research studies." As President, Talman will lead FASEB's advocacy efforts to encourage Congress and the Obama Administration to achieve the goal of sustainable funding for research.

A graduate of the University of Virginia School of Medicine, Talman's research focuses on the brain's control of the cardiovascular system, and his clinical specialty is autonomic dysfunction, for which he has been recognized by Best Doctors in America for the past eight years. Dr. Talman is the Past President of the International Society for Autonomic Neuroscience and past chair of the Public Affairs Committee of the American Physiological Society. He is also Associate Editor for Cellular and Molecular Neurobiology and has served as a reviewer for NIH Study Sections, VA Merit Review Boards, the National Science Foundation, and the American Heart Association.

Joseph C. LaManna, Ph.D., is FASEB's President-Elect and Fred D. Finkelman, M.D., the new Treasurer of the Federation. Dr. LaManna is a Professor of Physiology and Biophysics, Neurology and Neuroscience at the Case Western Reserve University School of Medicine and he has been involved as a cerebrovascular researcher for more than 30 years. Dr. Finkelman received his M.D. from Yale University and is a Professor of Medicine and Professor of Pediatrics at the University of Cincinnati College of Medicine.

FASEB is composed of 23 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve — through their research — the health, well-being, and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.


'/>"/>
SOURCE Federation of American Societies for Experimental Biology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FASEB Announces Recipient of the 2011 Excellence in Science Award
2. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
3. FASEB Encourages NIGMS to Broaden Scientific Training Opportunities
4. Laureate Pharma Welcomes Three New Members to Business Development Team
5. Sundia Welcomes Professional U.S. Delegation
6. NovaMin Technology Inc. Welcomes New Board Member
7. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
8. Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P. Gailitis, M.D., F.A.C.S.
9. UCLA welcomes startup to new incubator space at California NanoSystems Institute
10. Boston Scientific Welcomes Launch of Syntax Score Website
11. Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):